
Metapneumovirus
Human metapneumovirus (hMPV) causes respiratory tract infection especially in children. It was discovered in 2001 in the Netherlands. Similar to respiratory syncytial virus (RSV), hMPV is a member of the Paramyxoviridae family of viruses and has an RNA genome that encodes 8 viral proteins. The virus has a lipid envelope that contains viral glycoproteins that are involved in entry of the virus into cells and fusion of the viral envelope with cell membranes. There are two main genetic lineages termed subtype A and B each of which has two subgroups.
hMPV infection
hMPV is a relatively common virus infection that often resembles the common cold , however, symptoms indicative of more severe hMPV infections may occur in high risk patients such as infants, and the elderly and chronically ill. Most infections occur from October through April.
Transmission
hMPV is readily spread from contact with respiratory secretions from infected individuals or contaminated surfaces and objects.
Diagnosis
Clinicians are not able to accurately diagnose hMPV infection based on signs and symptoms alone. There are many other viruses that infect the respiratory tract and there is a large overlap of symptoms among these infections. Diagnostic tests performed on specimens taken from the respiratory tract provide a useful aid to the diagnosis of hMPV. The direct fluorescent antibody (DFA) method allows detection of virus within 2-3 hours, but is labor intensive and requires considerable experience. Molecular methods such as reverse transcription polymerase chain reaction (RT-PCR) based tests are the most accurate methods to detect hMPV.
Medical management of hMPV infection
Management of an hMPV infection is generally focused on symptomatic therapy. When an hMPV infection becomes more serious and progresses to bronchiolitis, patient management goals are to relieve respiratory distress, alleviate airway obstruction and improve oxygen levels. It is important to normalize body temperature and maintain proper hydration.
Prevention of hMPV infection
There is no vaccine for available for hMPV. Prevention of hMPV infection depends on good hygienic methods to reduce the spread of the virus.
Recommended Reading
Falsey AR (October 2008). "Human metapneumovirus infection in adults". Pediatr. Infect. Dis. J. 27 (10 Suppl): S80–3.
-
The Lyra RSV + hMPV Assay is a multiplex real-time PCR assay for the qualitative detection and identification of respiratory syncytial virus (RSV) and human...
-
Solana Respiratory Viral Panel (RVP) is a rapid qualitative in vitro diagnostic test for the detection and differentiation of respiratory syncytial...
-
The Solana RSV + hMPV Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of Respiratory Syncytial Virus (...
-
Solana RSV + hMPV Control Set
Other Offerings
Quidel also offers these other hMPV-related products:
-
For identification of all four identified subtypes of Metapneumovirus in both Direct Specimens and Rapid Culture.
-
Allows for the identification of RSV and MPV with DFA accuracy in under 25 minutes from specimen receipt to virus identification.
-
Allows for the detection of 8 viruses with DFA accuracy in under 25 minutes from specimen receipt to virus detection.